-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Remygen in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Remygen in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Remygen in Type 1 Diabetes (Juvenile Diabetes) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afizagabar in Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afizagabar in Ischemic Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afizagabar in Ischemic Stroke Drug Details: afizagabar (S-44819) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Parkinson's Disease Drug Details: Allopregnanolone (brexanolone) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Topiramate in Status Epilepticus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Topiramate in Status Epilepticus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Topiramate in Status Epilepticus Drug Details: Topiramate (PrevEp-004) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TP-04 in Rosacea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TP-04 in Rosacea report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TP-04 in Rosacea Drug Details: TP-04 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OV-329 in Seizures
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OV-329 in Seizures report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OV-329 in Seizures Drug Details: Small molecule is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GT-002 in Schizophrenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GT-002 in Schizophrenia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GT-002 in Schizophrenia Drug Details: GT-002 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Remimazolam Besylate in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Remimazolam Besylate in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Remimazolam Besylate in Pancreatic Cancer Drug Details: Remimazolam (Anerem, Byfavo,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Remimazolam Besylate in Biliary Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Remimazolam Besylate in Biliary Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Remimazolam Besylate in Biliary Tumor Drug Details: Remimazolam (Anerem, Byfavo,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Remimazolam Besylate in Gall Stone
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Remimazolam Besylate in Gall Stone report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Remimazolam Besylate in Gall Stone Drug Details: Remimazolam (Anerem, Byfavo,...